Englewood, CO – According to filings with the U.S. Securities and Exchange Commission, Vymedic is raising $3,000,000.00 in new funding. Sources indicate as part of senior management Chief Executive Officer, Cynthia Winning played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About Vymedic

Vymedic is a biotech company specializing in the research and development of amino acid based therapeutics. Vymedic’s amino acid science is focused on our breakthrough metabolic technology which allows us to deliver novel and transformative products designed to support health and maintain wellness. Our products are developed for use in immune support and over-the-counter medications for health management.

To learn more about Vymedic, visit http://vymedic.com/

Contact:
Cynthia Winning, Chief Executive Officer
303-699-4544
https://www.linkedin.com/in/cynthia-a-winning-ba16b01ab/

SOURCE: http://www.intelligence360.io
Copyright (c) 2020 SI360 Inc. All rights reserved